These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 24611168)
1. Infectious disease: Beating the big three. Bourzac K Nature; 2014 Mar; 507(7490):S4-7. PubMed ID: 24611168 [No Abstract] [Full Text] [Related]
2. A 2020 vision for vaccines against HIV, tuberculosis and malaria. Rappuoli R; Aderem A Nature; 2011 May; 473(7348):463-9. PubMed ID: 21614073 [TBL] [Abstract][Full Text] [Related]
3. The RV144 Thai HIV vaccine trial. Plotkin SA Hum Vaccin; 2010 Feb; 6(2):159. PubMed ID: 20431337 [No Abstract] [Full Text] [Related]
4. Convergent ethical issues in HIV/AIDS, tuberculosis and malaria vaccine trials in Africa: Report from the WHO/UNAIDS African AIDS Vaccine Programme's Ethics, Law and Human Rights Collaborating Centre consultation, 10-11 February 2009, Durban, South Africa. Mamotte N; Wassenaar D; Koen J; Essack Z BMC Med Ethics; 2010 Mar; 11():3. PubMed ID: 20211030 [TBL] [Abstract][Full Text] [Related]
5. The 2017 Keystone Symposium on HIV Vaccines. Cottrell CA; Ward AB Hum Vaccin Immunother; 2017 Oct; 13(10):2348-2351. PubMed ID: 28786733 [No Abstract] [Full Text] [Related]
6. AIDS research. Novel antibody response may explain HIV vaccine success. Cohen J Science; 2011 Sep; 333(6049):1560. PubMed ID: 21921167 [No Abstract] [Full Text] [Related]
7. Infectious disease. An enterprising time for HIV vaccine research. Cohen J Science; 2012 Sep; 337(6101):1446. PubMed ID: 22997300 [No Abstract] [Full Text] [Related]
8. RV144: old vs. new. Weiner DB Hum Vaccin; 2010 Feb; 6(2):159-61. PubMed ID: 20431335 [No Abstract] [Full Text] [Related]
9. Combined efforts in immunology and vaccinology will lead to effective vaccines against HIV, tuberculosis and malaria. Chiodi F; Kaufmann SH J Intern Med; 2014 May; 275(5):442-3. PubMed ID: 24635534 [No Abstract] [Full Text] [Related]
10. HIV/AIDS: vaccines and alternate strategies for treatment and prevention. Voronin Y; Phogat S Ann N Y Acad Sci; 2010 Sep; 1205 Suppl 1():E1-9. PubMed ID: 20860672 [TBL] [Abstract][Full Text] [Related]
11. HIV vaccine development: challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem. Koff WC Vaccine; 2012 Jun; 30(29):4310-5. PubMed ID: 22100891 [TBL] [Abstract][Full Text] [Related]
12. HIV Vaccines: One Step Closer. Low MSY; Tarlinton D Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424 [TBL] [Abstract][Full Text] [Related]
13. Novel tuberculosis vaccines on the horizon. Parida SK; Kaufmann SH Curr Opin Immunol; 2010 Jun; 22(3):374-84. PubMed ID: 20471231 [TBL] [Abstract][Full Text] [Related]
14. In pursuit of an HIV vaccine: an interview with Andrew McMichael. McMichael AJ BMC Biol; 2013 May; 11():60. PubMed ID: 23692824 [No Abstract] [Full Text] [Related]
15. The challenges of an HIV vaccine enterprise. Zinkernagel RM Science; 2004 Feb; 303(5662):1294-7; author reply 1294-7. PubMed ID: 14988536 [No Abstract] [Full Text] [Related]
16. Statistical methods for the analysis of clinical trials data containing many zeros: An application in vaccine development. Callegaro A; Kassapian M; Zahaf T; Tibaldi F Stat Methods Med Res; 2016 Dec; 25(6):2811-2826. PubMed ID: 24845724 [TBL] [Abstract][Full Text] [Related]
17. HIV vaccine development--improving on natural immunity. Johnston MI; Fauci AS N Engl J Med; 2011 Sep; 365(10):873-5. PubMed ID: 21899447 [No Abstract] [Full Text] [Related]
18. In vivo protection by broadly neutralizing HIV antibodies. van Gils MJ; Sanders RW Trends Microbiol; 2014 Oct; 22(10):550-1. PubMed ID: 25169020 [TBL] [Abstract][Full Text] [Related]
19. Dancing with an escape artist. Deweerdt S Nature; 2010 Jul; 466(7304):S6-7. PubMed ID: 20631705 [No Abstract] [Full Text] [Related]
20. Cell-mediated immunity needed for TB vaccine. Indian J Med Sci; 1998 Nov; 52(11):521-2. PubMed ID: 10218297 [No Abstract] [Full Text] [Related] [Next] [New Search]